( NASDAQ-SMALL:CRME, Toronto:COM )

News from Cardiome Pharma Corp. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 10, 2018, 08:00 ET Cardiome to Participate in the Cantor Fitzgerald Antibiotics Summit

NASDAQ:CRME TSX:COM VANCOUVER, Jan. 10, 2018 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty...


Dec 12, 2017, 08:00 ET Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia

NASDAQ:CRME TSX:COM VANCOUVER, Dec. 12, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty...


Dec 11, 2017, 08:00 ET Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission

NDA Expected to be Filed and Accepted by the End of 2018 NASDAQ:CRME TSX:COM VANCOUVER, Dec. 11, 2017 /PRNewswire/ - Cardiome Pharma Corp....


Dec 11, 2017, 06:00 ET Cardiome Announces Xydalba™ Treatment And Patient Experience Presentations At The 2017 National Opat Conference

NASDAQ:CRME TSX:COM Plenary Symposium Features Three Experts Discussing Clinical Use VANCOUVER, Dec. 11, 2017 /PRNewswire/ - Cardiome Pharma...


Nov 20, 2017, 08:00 ET Cardiome to Present at the 29th Annual Piper Jaffray Healthcare Conference

NASDAQ: CRME TSX: COM VANCOUVER, Nov. 20, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty...


Nov 14, 2017, 16:01 ET Cardiome Reports Third Quarter 2017 Financial Results

NASDAQ: CRME TSX: COM Management to Host Conference Call and Webcast Today, November 14, 2017 at 4:30 p.m. ET (1:30 p.m. PT) VANCOUVER, Nov. 14,...


Nov 07, 2017, 08:00 ET Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14

NASDAQ: CRME TSX: COM VANCOUVER, Nov. 7, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty...


Nov 02, 2017, 08:00 ET Cardiome Announces Expansion of Global Geographic Footprint for Brinavess®

– Brinavess® Launched This Week in South Africa; New Distribution Agreement Signed for Pakistan – NASDAQ: CRME TSX: COM VANCOUVER, Nov. 2,...


Oct 30, 2017, 08:00 ET Cardiome Announces Commercial Launch of Xydalba™ in Three New European Geographies

Marketing and Promotion of Xydalba Has Now Commenced in Six European Countries NASDAQ:CRME TSX:COM VANCOUVER, Oct. 30, 2017 /PRNewswire/ -...


Sep 12, 2017, 07:00 ET Cardiome Announces Agreement with Basilea for Distribution of Zevtera®/Mabelio® (Ceftobiprole) in Europe and Israel

VANCOUVER, Sept. 12, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has entered into a distribution...


Sep 05, 2017, 08:00 ET Cardiome to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

NASDAQ: CRME TSX: COM VANCOUVER, Sept. 5, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Dr. Bill...


Aug 30, 2017, 08:00 ET New Data Presented at European Society of Cardiology Congress 2017 Highlights Clinical Benefit of BRINAVESS®

Results Support the Clinical Utility of BRINAVESS as a Treatment Alternative to Electrical Cardioversion in Patients with Recent Onset Atrial...


Aug 21, 2017, 08:00 ET Cardiome Provides U.S. Regulatory Update For BRINAVESS

NASDAQ:CRME TSX:COM VANCOUVER, Aug. 21, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME/ TSX:COM) today announced that it has received a...


Aug 08, 2017, 16:00 ET Cardiome Reports Second Quarter 2017 Financial Results

NASDAQ: CRME TSX: COM Management to Host Conference Call and Webcast Today, August 8, 2017 at 4:30 p.m. ET (1:30 p.m. PT) VANCOUVER, Aug. 8, 2017...


Aug 01, 2017, 08:00 ET Cardiome To Hold Second Quarter 2017 Financial Results Conference Call On August 8

NASDAQ: CRME TSX: COM VANCOUVER, Aug. 1, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report...


Jul 17, 2017, 08:00 ET Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen

NASDAQ: CRME TSX: COM VANCOUVER, July 17, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that the Therapeutic...


Jul 03, 2017, 08:00 ET Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial Hypertension

NASDAQ:CRME TSX:COM VANCOUVER, July 3, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that partner SteadyMed...


Jun 23, 2017, 08:00 ET Cardiome Pharma Corp. Announces Voting Results

NASDAQ:CRME TSX:COM VANCOUVER, June 23, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the results of...


Jun 21, 2017, 08:00 ET Cardiome Announces Licensing Agreement for XYDALBA™ (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel

NASDAQ:CRME TSX:COM VANCOUVER, June 21, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that its affiliate...


Jun 12, 2017, 07:30 ET Cardiome Announces Commercial Launch of BRINAVESS® (Vernakalant Hydrochloride) in Canada

NASDAQ:CRME TSX:COM VANCOUVER, June 12, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that it received...


May 16, 2017, 08:00 ET Cardiome Reports Changes To Senior Management Team

NASDAQ: CRME TSX: COM VANCOUVER, May 16, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced a number of changes...


May 15, 2017, 16:00 ET Cardiome Reports First Quarter 2017 Financial Results

NASDAQ: CRME TSX: COM Cardiome to conduct conference call and webcast today, May 15, 2017 at 4:30 p.m. Eastern (1:30 p.m. Pacific) VANCOUVER,...


May 15, 2017, 08:00 ET Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds

NASDAQ: CRME TSX: COM VANCOUVER, May 15, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") today...


May 08, 2017, 08:00 ET Cardiome To Hold First Quarter 2017 Financial Results Conference Call On May 15

NASDAQ: CRME TSX: COM VANCOUVER, May 8, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report...


Apr 27, 2017, 08:00 ET Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference

NASDAQ: CRME TSX: COM VANCOUVER, April 27, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that David Dean, VP...